Literature DB >> 21401644

Real-time PCR detection of Parvicapsula pseudobranchicola (Myxozoa: Myxosporea) in wild salmonids in Norway.

A Jørgensen1, A Nylund, V Nikolaisen, S Alexandersen, E Karlsbakk.   

Abstract

The myxozoan genus Parvicapsula contains 14 species infecting fish, some of which are known to cause severe disease in farmed and wild salmonids. Parvicapsula pseudobranchicola infections were first reported from seawater-reared Atlantic salmon, Salmo salar, in Norway in 2002 and have since then been an increasing problem. The present study describes a Taqman real-time PCR assay for specific detection of P. pseudobranchicola. The Taqman assay targets the 18S rRNA gene of P. pseudobranchicola and is able to detect as few as ten copies of the target sequence. Using the described assay, P. pseudobranchicola was detected in both farmed and wild salmonids, indicating that wild Atlantic salmon, sea trout, Salmo trutta, and Arctic char, Salvelinus alpinus, may be natural hosts of the parasite. Parvicapsula pseudobranchicola was found in samples from wild salmonids in the far south and the far north of Norway, displaying a wide geographic range of the parasite. Farmed salmonids showed P. pseudobranchicola infection levels many folds higher than that observed for wild sea trout, indicating that farmed Atlantic salmon are subjected to an elevated infection pressure compared with wild salmonids.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21401644     DOI: 10.1111/j.1365-2761.2011.01248.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  7 in total

1.  Handling, infectious agents and physiological condition influence survival and post-release behaviour in migratory adult coho salmon after experimental displacement.

Authors:  J M Chapman; A K Teffer; A L Bass; S G Hinch; D A Patterson; K M Miller; S J Cooke
Journal:  Conserv Physiol       Date:  2020-05-18       Impact factor: 3.252

2.  Seatrout (Salmo trutta) is a natural host for Parvicapsula pseudobranchicola (Myxozoa, Myxosporea), an important pathogen of farmed Atlantic salmon (Salmo salar).

Authors:  Haakon Hansen; Trygve T Poppe; Turhan Markussen; Egil Karlsbakk
Journal:  Parasit Vectors       Date:  2015-04-10       Impact factor: 3.876

3.  Detection of the myxosporean parasite Parvicapsula pseudobranchicola in Atlantic salmon (Salmo salar L.) using in situ hybridization (ISH).

Authors:  Turhan Markussen; Celia Agusti; Egil Karlsbakk; Are Nylund; Øyvind Brevik; Haakon Hansen
Journal:  Parasit Vectors       Date:  2015-02-15       Impact factor: 3.876

4.  Infection dynamics and tissue tropism of Parvicapsula pseudobranchicola (Myxozoa: Myxosporea) in farmed Atlantic salmon (Salmo salar).

Authors:  Are Nylund; Haakon Hansen; Øyvind J Brevik; Håvard Hustoft; Turhan Markussen; Heidrun Plarre; Egil Karlsbakk
Journal:  Parasit Vectors       Date:  2018-01-06       Impact factor: 3.876

5.  Selection of suitable reference genes for gene expression studies in myxosporean (Myxozoa, Cnidaria) parasites.

Authors:  Anush Kosakyan; Gema Alama-Bermejo; Pavla Bartošová-Sojková; Ana Born-Torrijos; Radek Šíma; Anna Nenarokova; Edit Eszterbauer; Jerri Bartholomew; Astrid S Holzer
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

6.  Capture severity, infectious disease processes and sex influence post-release mortality of sockeye salmon bycatch.

Authors:  Amy K Teffer; Scott G Hinch; Kristi M Miller; David A Patterson; Anthony P Farrell; Steven J Cooke; Arthur L Bass; Petra Szekeres; Francis Juanes
Journal:  Conserv Physiol       Date:  2017-03-28       Impact factor: 3.079

7.  Comparison of infectious agents detected from hatchery and wild juvenile Coho salmon in British Columbia, 2008-2018.

Authors:  Omid Nekouei; Raphael Vanderstichel; Karia H Kaukinen; Krishna Thakur; Tobi Ming; David A Patterson; Marc Trudel; Chrys Neville; Kristina M Miller
Journal:  PLoS One       Date:  2019-09-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.